Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724244 | SCV000230648 | uncertain significance | not provided | 2014-10-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724244 | SCV000329183 | uncertain significance | not provided | 2024-12-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25633834) |
Labcorp Genetics |
RCV000525777 | SCV000627571 | likely benign | Long QT syndrome | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345623 | SCV002652320 | likely benign | Cardiovascular phenotype | 2022-10-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |